Exposure Status | Controls | LHC Cases | MPD | MDS | Leukaemia | Lymphoma | PcD |
---|---|---|---|---|---|---|---|
Low/No (Ref) | 124 (27.2%) | 72 (20.3%) | 18 (26.1%) | 13 (16.7%) | 11 (14.9%) | 20 (26.7%) | 10 (17.2%) |
Medium | 140 (30.8%) | 99 (28.0%) | 15 (21.7%) | 23 (29.5%) | 18 (24.2%) | 24 (32.0%) | 19 (32.8%) |
High | 191 (42.0%) | 183 (51.7%) | 36 (52.2%) | 42 (53.8%) | 45 (60.9%) | 31 (41.3%) | 29 (50.0%) |
OR Medium vs Low/No (95% CI) | Ref | 1.22 (0.81-1.83) | 0.74 (0.35-1.73) | 1.57 (0.72-3.43) | 1.45 (0.62-3.43) | 1.06 (0.54-2.12) | 1.68 (0.71-4.05) |
OR High vs Low/No (95% CI) | Ref | 1.65 (1.14-2.39) | 1.37 (0.71-2.68) | 2.10 (1.04-4.30) | 2.66 (1.27-5.68) | 1.01 (0.62-2.23) | 1.88 (0.84-4.30) |
OR Exposed vs Non exposed (Medium and High vs Low/No) (95% CI) | Ref | 1.46* (1.05-2.04) | 1.06 (0.59-1.88) | 1.87* (1.00-3.51) | 2.14* (1.09-4.20) | 1.03 (0.59-1.79) | 1.79 (0.88-3.66) |